Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARTRYA LIMITED Director's Dealing 2022

Dec 11, 2022

64483_rns_2022-12-11_cbd048e5-b6e7-4839-8196-9a8e1ae10382.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Artrya Limited ACN 624 005 741

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director John Barrington
Date of last notice 21 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

thispart.
Direct or indirect interest Direct and Indirect
Nature of indirect interest Indirect – Australian Executor Trustees Ltd
(including registered holder) <Barrington & Harris Superannuation Fund
Note: Provide details of the circumstances giving rise to the relevantinterest. A/C> - John Barrington is a trustee and
beneficiary.
Date of change 6 December 2022
No. of securities held prior to change Mr John Barrington <BHT Family A/C>
•7,117,945 ordinary fully paid shares
(Shares) subject to ASX escrow until
26 November 2023
•222,965 Shares subject to voluntary
escrow until 26 November 2022
•3,000,000 Options exercisable at
$0.001 each on or before 25 March
2024, subject to ASX escrow until 26
November 2023.
•2,000,000 Options exercisable at
$1.00 each on or before 9 July 2026,
subject to ASX escrow until 26
November 2023.
•439,815 Performance Rights expiring
30 June 2025
Australian Executor Trustees Ltd <Barrington &
Harris Superannuation Fund A/C>
•252,185 Shares

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y

Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Ordinary Shares
Number acquired 222,965 shares
Number disposed 222,965 shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation $110,367.68
No. of securities held after change Mr John Barrington <BHT Family A/C>•7,117,945 ordinary fully paid shares(Shares) subject to ASX escrow until26 November 2023•3,000,000 Options exercisable at$0.001 each on or before 25 March2024, subject to ASX escrow until 26November 2023.•2,000,000 Options exercisable at$1.00 each on or before 9 July 2026,subject to ASX escrow until 26November 2023.•439,815 Performance Rights expiring30 June 2025Australian Executor Trustees Ltd <Barrington &Harris Superannuation Fund A/C>•475,150 Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back Off-market transfer

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation towhich the interest has changed N/A

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? N/A
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y

Page 3